1. Identify the product
A brand name is a start, not proof. The actual drug, device, lot, model, formulation, dose or exposure site must be connected to records.
Drug, device, and product lawsuits
Explore current claims involving dangerous drugs, defective medical devices, toxic exposure, consumer products, and online harm. Each guide explains what happened, what the evidence says, where the litigation stands, and what an attorney may need to review your claim.
No fee to submit an intake. No attorney-client relationship is formed unless a law firm accepts the matter in writing.
Read the status before the headline
A mass tort is a group of individual injury claims that share a product, exposure or defendant. Federal courts may coordinate related cases in multidistrict litigation, or MDL, to manage common discovery, expert questions and pretrial motions. The cases do not automatically become one class action. Exposure, diagnosis, timing, state law, causation and damages remain individual.
A brand name is a start, not proof. The actual drug, device, lot, model, formulation, dose or exposure site must be connected to records.
A symptom, diagnosis and treatment are different facts. Strong screening uses medical records and the most specific diagnosis available.
Active, emerging, advanced and settlement-phase matters have different deadlines, evidence rules and intake realities.
Current case directory
Pending-action counts are from the JPML report dated July 1, 2026. They are docket snapshots—not claimant totals, settlement forecasts or findings of liability.
Federal cases allege that repeated or long-term medroxyprogesterone acetate injections contributed to intracranial meningioma and that earlier warnings were inadequate. Defendants deny liability.
The litigation concerns alleged kidney injuries after use of prescription and over-the-counter proton-pump inhibitors, including claims about warning adequacy.
Cases allege gastroparesis, ileus, intestinal obstruction, severe vomiting or related injuries after use of semaglutide, tirzepatide and other GLP-1 medicines.
Cases allege severe tooth decay, infection, fracture or loss after use of Suboxone film or other buprenorphine medicines dissolved in the mouth.
Claims concern certain recalled lots of generic valsartan, losartan or irbesartan that contained nitrosamine impurities above FDA limits.
Claims allege long-term ranitidine use exposed consumers to NDMA and contributed to certain cancers. Federal and state proceedings have had different evidentiary histories.
Cases allege that long-term Elmiron exposure contributed to pigmentary maculopathy and progressive vision injury and that earlier warnings were inadequate.
Claims allege that Tepezza can cause tinnitus or severe and sometimes permanent hearing impairment and that warnings or monitoring instructions were inadequate.
Cases allege that semaglutide or other identified GLP-1 treatment contributed to NAION, a sudden optic-nerve injury causing vision loss.
Plaintiffs allege specified injuries after HPV vaccination and challenge warnings or marketing. CDC and FDA continue to recommend HPV vaccination based on safety and cancer-prevention benefits.
Newly centralized cases allege that Dupixent can cause, accelerate or mask cutaneous T-cell lymphoma in patients treated for conditions such as atopic dermatitis.
Plaintiffs allege that forced-air warming systems used during joint-replacement procedures can disrupt operating-room airflow and contribute to deep surgical-site infection. Defendants dispute causation.
Cases concern inferior vena cava filters alleged to fracture, migrate, tilt, perforate or become difficult to retrieve after the temporary clot risk has passed.
Claims allege that Paragard copper intrauterine devices can break during removal, leaving fragments that require hysteroscopy, laparoscopy or other treatment.
Claims allege that identified Bard implantable ports or catheters can degrade, fracture, migrate, leak or contribute to thrombosis or infection.
Claims concern recurrence, adhesion, migration, infection, bowel injury, fistula, chronic pain or revision after implantation of specific hernia mesh products.
Claims allege that defective packaging allowed oxidation of polyethylene components, contributing to premature wear, bone loss, loosening or revision.
The litigation concerns recalled Allergan BIOCELL textured breast implants and tissue expanders associated with breast implant-associated anaplastic large cell lymphoma.
The recall concerns degradation of polyester-based polyurethane sound-abatement foam in specified Philips respiratory devices and potential inhalation or ingestion of particles or chemicals.
Newly coordinated cases concern specified Boston Scientific spinal cord stimulation systems and allegations of malfunction, loss of therapy, shocks, burns or revision injury.
Cases concern Cartiva synthetic cartilage implants used in the big-toe joint and alleged subsidence, displacement, fragmentation, pain or revision.
Claims allege exposure to PFAS in aqueous film-forming foam through firefighting work, military service, airports, training facilities or contaminated water.
Claims allege that occupational or agricultural paraquat exposure contributed to Parkinson's disease and that warnings were inadequate. EPA says it has not found a clear link from labeled uses.
Plaintiffs allege that repeated glyphosate-based herbicide exposure contributed to non-Hodgkin lymphoma. EPA and IARC have reached different hazard conclusions.
Claims generally concern cosmetic talc use, alleged asbestos contamination, ovarian cancer or mesothelioma. The scientific and product-identification questions differ by disease and exposure route.
Cases allege that repeated use of certain chemical hair-straightening products contributed to uterine, endometrial or ovarian cancer and that warnings were inadequate.
Families allege that cow's-milk-based formula or fortifier products increased the risk of NEC in premature infants and were sold without adequate warnings.
Families allege that repeated consumption of identified baby foods containing toxic elements contributed to autism spectrum disorder or other neurodevelopmental injury.
Cases arise from infant botulism associated with recalled ByHeart powdered infant formula. FDA says the outbreak ended in February 2026 while root-cause work continued.
Families allege that platform design features contributed to compulsive use and serious mental-health injuries in children or adolescents. Platforms contest liability and causation.
How a mass tort claim is evaluated
A current MDL is not an invitation to file every complaint involving a named product. It is a procedure for coordinating federal cases that share factual questions. Before a law firm can responsibly decide whether to investigate, it usually needs a verifiable exposure, a medically documented injury and a timeline that makes legal and scientific sense. Product identification can come from pharmacy claims, implant stickers, device serial numbers, military or employment records, receipts, photographs, hospital invoices, feeding logs, salon history or witnesses. The right record depends on the case.
The injury must also be specific. “Stomach problems” is not the same as a documented gastric-emptying study and gastroparesis diagnosis. “Vision changed” is not the same as a neuro-ophthalmologist diagnosing NAION. A recalled implant is not necessarily a failed implant. This does not mean people need every record before asking for help. It means the first conversation should identify where the records are and what they may prove.
Mass-tort websites often turn a study headline into a causation statement. That is not how medical evidence works. A case report can identify a signal but cannot calculate risk. An observational study can find an association but may be affected by confounding, exposure measurement and selection. A randomized trial answers a different question but may be too small or short to identify a rare delayed injury. An FDA warning, recall or label change is important regulatory evidence, yet it does not decide whether a product legally caused one person's condition.
LawIntaker therefore pairs the litigation allegation with the regulator's position, current labeling and relevant medical literature. When respected authorities disagree—as EPA and IARC do about glyphosate hazard classification—the guide says so. Readers deserve to see uncertainty and competing interpretations, because an attorney and qualified experts must eventually address those issues in an individual claim.
A verdict is the result of one trial on one record. It may be reduced, reversed, retried or settled during appeal. A bellwether is intended to test recurring evidence and arguments; it does not set a price for every case. A public-water PFAS settlement compensates water systems for treatment costs and is not a personal-injury settlement. An economic-loss recall program is different from compensation for cancer, surgery or permanent disability.
That is why this directory does not publish invented “average settlements.” Where a company, court or settlement administrator has announced a resolution, the individual guide identifies what it covers and links to the source. If the official sources do not show a global settlement, the page says so. No result can promise what another person will recover.
Statutes of limitation vary by state and can turn on injury, diagnosis, discovery, product identification, residence, purchase, treatment or a defendant's conduct. MDL judges may also set census, registration, proof-of-use, settlement or dismissal deadlines. Bankruptcy and claims-administration proceedings can create separate bar dates. Waiting for a television commercial or a future settlement can be risky. Only a lawyer applying the relevant law to the facts can give deadline advice.
LawIntaker collects basic routing information and does not decide legal eligibility. A participating legal team may ask for authorization to obtain medical or product records, compare the facts with current case criteria, investigate product identification, evaluate jurisdiction and deadlines, and discuss a representation agreement. Submitting information does not file a lawsuit, stop a deadline or create an attorney-client relationship. That relationship begins only if a law firm accepts the matter in writing.
People should continue following qualified medical advice. Do not stop a prescription, remove an implant, discard a device or change a child's treatment because of a lawsuit page. Ask a healthcare professional about medical decisions and preserve the product or records when doing so is safe. For urgent symptoms, call 911 or seek immediate medical care.